Article Information
History
- April 5, 2024.
Article Versions
- Version 1 (March 27, 2024 - 12:00).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Azlann Arnetta,e,
- David A. Siegelb,
- Shifan Daic,
- Trevor D. Thompsonb,
- Jennifer Fostera,e,
- Erika J. di Pierroa,e,
- Behnoosh Mominb,
- Philip J. Lupoa,d,e and
- Andras Heczeya,e,*
- aCancer and Hematology Centers, Texas Children’s Hospital, Houston, Texas
- bDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
- cCyberdata Technologies, Inc., Herndon, Virginia
- dCenter for Epidemiology and Population Health, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- eDivision of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- ↵*Corresponding Author:
Andras Heczey MD; Address: 1102 Bates Avenue C1760.10, Houston, TX, 77025. Phone: 832-824-4233; E-mail: heczey{at}bcm.edu
Posted April 05, 2024.
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020
